V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005156 | 290003765 | 1.54 | 87.1 | Adjuvant (A) | null | 2015-10-04 | LANREOTIDE | N | Y | 290022454 | CAPECITABINE + RT |
| 290005157 | 290003766 | 1.8 | 65.3 | Palliative (P) | 2017-01-16 | 2017-01-18 | Capecitabine 42days + RT | N | N | 290022461 | CAPECITABINE + RT |
| 290005158 | 290003766 | 1.54 | null | null | 2017-08-12 | 2017-08-01 | Capecitabine | 02 | N | 290022461 | IRINOTECAN + MDG |
| 290005159 | 290007789 | 1.78 | 65.1 | Palliative (P) | 2015-03-28 | 2015-03-30 | LANREOTIDE | N | N | 290022464 | OCTREOTIDE |
| 290005160 | 290003767 | 1.64 | 78 | Palliative (P) | 2013-10-10 | 2013-10-10 | Cetuximab 14 day | N | N | 290022465 | LANREOTIDE |
| 290005161 | 290003768 | 1.58 | 48 | Palliative (P) | 2017-07-19 | 2017-08-09 | CETUXIMAB + RT | 02 | N | 290022470 | CAPECITABINE + GEMCITABINE |
| 290005162 | 290003769 | 1.7 | 68.4 | Neo-adjuvant (N) | 2017-04-04 | 2017-04-04 | Capecitabine 35days + RT | N | N | 290022471 | CAPECITABINE + RT |
| 290005163 | 290003770 | 1.75 | 65.2 | Palliative (P) | 2016-02-24 | 2016-05-27 | Capecitabine (21days) + Carboplatin | N | Y | 290022475 | CETUXIMAB + IRINOTECAN + MDG |
| 290005164 | 290003771 | null | 56.15 | Palliative (P) | 2017-07-29 | 2017-08-18 | CISPLATIN + FLUOROURACIL | N | N | 290022478 | CAPECITABINE |
| 290005165 | 290003771 | null | null | Neo-adjuvant (N) | 2014-10-16 | 2014-11-20 | Capecitabine 35days + RT | 02 | Y | 290022478 | CAPECITABINE + RT |
| 290005166 | 290003772 | 1.75 | 81.6 | null | 2017-10-19 | 2017-10-19 | CompARE Trial | 02 | N | 290022483 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005167 | 290006623 | 1.59 | null | Adjuvant (A) | 2014-01-15 | 2014-01-25 | Temozolomide + RT | N | N | 290022484 | LANREOTIDE |
| 290005168 | 290003773 | 1.64 | 65.7 | Palliative (P) | 2018-01-02 | 2018-01-02 | Trial Unspecified | N | N | 290022486 | CETUXIMAB |
| 290005169 | 290003774 | 1.68 | 68 | Neo-adjuvant (N) | 2014-06-05 | 2014-06-30 | LANREOTIDE | N | N | 290022491 | CETUXIMAB |
| 290005170 | 290003775 | 1.76 | 92 | Curative (C) | 2013-12-01 | 2016-07-01 | Cisplatin + Etoposide (3 day) | N | Y | 290022492 | CISPLATIN + VINORELBINE |
| 290005171 | 290003776 | 1.81 | 98.8 | Neo-adjuvant (N) | 2017-04-08 | 2017-04-21 | CARBOPLATIN + RT | 2 | null | 290022494 | FCARBOST |
| 290005172 | 290003777 | 1.7 | 72 | Palliative (P) | 2014-11-14 | 2014-12-16 | Capecitabine 35days + RT | N | N | 290022495 | CAPECITABINE + RT |
| 290005173 | 290003778 | null | 61 | Palliative (P) | 2017-04-20 | 2017-04-28 | LANREOTIDE | 02 | null | 290022499 | CARBOPLATIN + PACLITAXEL |
| 290005174 | 290003779 | 1.6 | 61.1 | Neo-adjuvant (N) | 2014-06-28 | 2014-07-11 | CAPECITABINE + RT | Y | Y | 290022501 | CAPECITABINE |
| 290005175 | 290003780 | 1.65 | 50 | Palliative (P) | 2018-06-20 | 2018-06-28 | CISPLATIN + FLUOROURACIL | 01 | N | 290022503 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290005176 | 290003781 | 1.74 | 68.8 | Palliative (P) | 2015-09-28 | 2015-10-30 | Irinotecan + De Gramont | 2 | N | 290022506 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005177 | 290003781 | 1.75 | 33.5 | Curative (C) | 2014-12-16 | 2014-12-23 | Bevacizumab+Carbo+Pacliaxel | Y | Y | 290022506 | CAPECITABINE |
| 290005178 | 290003782 | 1.79 | 84 | Palliative (P) | 2014-06-15 | 2014-06-16 | Capecitabine + Cisplatin | 02 | null | 290022509 | CYTARABINE |
| 290005179 | 290003782 | 1.85 | null | Adjuvant (A) | 2013-01-06 | 2014-09-20 | Cetuximab 14 day | 02 | N | 290022509 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005180 | 290003782 | 1.59 | 60.4 | Palliative (P) | null | 2017-02-26 | Trial Unspecified | N | N | 290022509 | CAPECITABINE + RT |
| 290005181 | 290003783 | 1.83 | 82.1 | Neo-adjuvant (N) | 2015-03-22 | 2015-03-26 | LANREOTIDE | 02 | N | 290022515 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005182 | 290003784 | 1.65 | null | Curative (C) | 2013-07-15 | 2013-08-04 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290022520 | FLUOROURACIL |
| 290005183 | 290003785 | 1.6 | null | Radical (R) | 2017-08-30 | 2017-08-30 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 290022524 | CISPLATIN + FLUOROURACIL |
| 290005184 | 290006626 | 0 | 57 | Palliative (P) | 2013-10-28 | 2013-10-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022525 | LANREOTIDE |
| 290005185 | 290003786 | 1.7 | 47.2 | Curative (C) | 2013-07-21 | 2013-08-01 | Capecitabine 42days + RT | null | N | 290022526 | CAPECITABINE |
| 290005186 | 290003787 | 0 | 67.8 | null | 2016-10-30 | 2017-10-15 | Irinotecan + Modified De Gramont | 02 | N | 290022527 | CAPECITABINE + CISPLATIN |
| 290005187 | 290003787 | 1.76 | 74.1 | Palliative (P) | 2016-02-07 | 2016-02-07 | LANREOTIDE | 2 | N | 290022527 | CETUXIMAB + RT |
| 290005188 | 290003788 | 1.7 | 65.5 | Neo-adjuvant (N) | 2016-10-07 | 2016-10-07 | Capecitabine 42days + RT | 01 | N | 290022531 | LANREOTIDE |
| 290005189 | 290006628 | 1.69 | 63.4 | Curative (C) | 2015-08-20 | 2015-08-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 290022533 | CAPECITABINE + CARBOPLATIN |
| 290005190 | 290006628 | 1.79 | null | Curative (C) | null | 2016-09-21 | ECX | N | N | 290022533 | GEMCITABINE |
| 290005191 | 290003789 | 1.66 | 78 | Palliative (P) | 2016-05-17 | 2016-05-23 | CHLVPP | 02 | N | 290022540 | CETUXIMAB + RT |
| 290005192 | 290003790 | 1.79 | 91 | Palliative (P) | 2013-08-28 | 2013-08-29 | Cetuximab 14 day | 02 | N | 290022541 | CHOP R |
| 290005193 | 290003791 | 1.68 | 54.7 | Curative (C) | 2014-11-11 | 2014-11-19 | LANREOTIDE | 2 | Y | 290022543 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005194 | 290003792 | 1.69 | 85 | Neo-adjuvant (N) | 2017-02-03 | 2017-02-03 | Capecitabine 35days + RT | N | N | 290022544 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005195 | 290003793 | 1.78 | 83.1 | Palliative (P) | 2016-08-14 | 2016-09-08 | CHOP R - 21 days | N | N | 290022546 | ECARBOF |
| 290005196 | 290003794 | 1.7 | null | Palliative (P) | 2014-07-12 | 2014-07-17 | OCTREOTIDE | N | N | 290022550 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005197 | 290003795 | null | null | Palliative (P) | null | 2013-05-12 | CAPECITABINE + RT | N | N | 290022553 | CISPLATIN + FLUOROURACIL |
| 290005198 | 290003796 | 1.75 | 63.5 | Palliative (P) | 2017-05-28 | 2017-06-10 | Rituximab (Maintenance) | 2 | N | 290022554 | DACARBAZINE |
| 290005199 | 290003797 | 1.55 | 95.6 | Not known (9) | 2015-02-25 | 2015-03-13 | EVEROLIMUS | null | N | 290022556 | LANREOTIDE |
| 290005200 | 290003798 | 1.58 | null | Palliative (P) | 2015-05-10 | 2015-05-19 | LANREOTIDE | 2 | N | 290022558 | PLATO TRIAL |
| 290005201 | 290003799 | 1.75 | 121 | Neo-adjuvant (N) | 2017-12-09 | 2017-12-14 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | N | 290022559 | FLUOROURACIL |
| 290005202 | 290003800 | 0 | 97.4 | Neo-adjuvant (N) | 2017-11-07 | 2017-11-09 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290022560 | FLUOROURACIL |
| 290005203 | 290003801 | 1.66 | 90.5 | Palliative (P) | 2013-04-05 | 2013-04-09 | CARBOPLATIN + PACLITAXEL | 02 | N | 290022562 | CETUXIMAB + RT |
| 290005204 | 290003801 | 1.72 | null | Curative (C) | 2017-06-04 | 2017-06-05 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 290022562 | FLUOROURACIL + RT |
| 290005205 | 290003802 | 1.65 | null | Curative (C) | 2015-05-09 | 2015-05-15 | CARBOPLATIN + PACLITAXEL | 01 | N | 290022565 | CAPECITABINE |